Enfuvirtide, a new drug for HIV infection.
Fletcher
Courtney V
CV
Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA. courtney.fletcher@uchsc.edu <courtney.fletcher@uchsc.edu>
D000077560:Enfuvirtide; D005260:Female; D015700:HIV Envelope Protein gp41 / Q000097:blood / Q000187:drug effects* / Q000378:metabolism / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006207:Half-Life; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide